Increase to 500 mcg on the second or third injection if tolerated
Among people without diabetes, the increase was even more dramatic at 643%, climbing from roughly 115,000 to 855,000 adults over the same period
Cardiovascular outcome trials have demonstrated reductions in major adverse cardiovascular events in high-risk patients, prompting investigation into their effects on various cardiovascular risk factors, including lipid profiles
However, it remains less explored how the receptor interacts with proteins on the cell membrane
Call 999 or go to your nearest A&E immediately if you experience: Signs of a severe allergic reaction (anaphylaxis), including swelling of the face, lips, tongue, or throat, difficulty breathing, or a widespread rash with collapse Seek urgent medical advice if you experience: Severe or persistent vomiting that prevents you from keeping fluids down Signs of dehydration, including dizziness, dark urine, or significantly reduced urination Severe abdominal pain, particularly if it radiates to the back this may indicate pancreatitis, a rare but serious adverse effect associated with GLP-1 receptor agonists [11] [12] Pain in the upper right abdomen, fever, yellowing of the skin or eyes (jaundice), pale stools, or dark urine these may be signs of a gallbladder problem, such as gallstones or cholecystitis, which have been associated with this class of medicine and with rapid weight loss Symptoms of hypoglycaemia (low blood sugar), such as shakiness, sweating, confusion, or palpitations the risk is higher if you are also taking insulin or a sulfonylurea
Clinical guidelines to reduce GLP-1 side effects involve making changes to lifestyle habits something your doctor probably doesnt have time to help you implement
